Methods of treating tobacco smoking addiction, and treating nicotine and tobacco smoking addiction

A method of treating nicotine and tobacco smoking addiction, comprising:

• treating withdrawal symptoms of a nicotine deficiency in a human body induced by the human body being deprived from smoking tobacco, comprising administering a nicotinic agonist, or precursor thereof;
• and
• parallel in time with treating the withdrawal symptoms of the nicotine deficiency, treating a craving for smoking tobacco by inhibiting or suppressing the craving, the treating comprising administering a non-psychoactive cannabinoid, or precursor thereof;
• said treating withdrawal symptoms of the nicotine deficiency and said treating a craving for smoking tobacco comprising:
• using a series of products over a period of time, with a time-interval between subsequent products, to administer the nicotinic agonist and the non-psychoactive cannabinoid in-vivo to the human body through a tobacco- and smokeless delivery route, each product comprising:
• a therapeutically effective amount of the nicotinic agonist, or precursor thereof, in a pharmaceutically acceptable form suitable to release in-vivo in the human body a dose of the nicotinic agonist tolerable by the human body and effective to treat the withdrawal symptoms of the nicotine deficiency;
• and
• a therapeutically effective amount of the non-psychoactive cannabinoid, or precursor thereof, in a pharmaceutically acceptable form suitable to release in-vivo in the human body a dose of the non-psychoactive cannabinoid tolerable by the human body and effective to inhibit or suppress the craving;
• wherein the amount and/or form of the nicotinic agonist, or precursor thereof, in the product differ between products in said series to gradually reduce the dose of the nicotinic agonist over time and get the human body gradually accustomed to the absence of extraneous nicotine absorbed in the human body by smoking tobacco.